ciprofloxacin has been researched along with Diabetic Feet in 27 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Calcium alginate (CA) wafer dressings were prepared by lyophilization of hydrogels to deliver ciprofloxacin (CIP) directly to the wound site of infected diabetic foot ulcers (DFUs)." | 7.88 | Ciprofloxacin-loaded calcium alginate wafers prepared by freeze-drying technique for potential healing of chronic diabetic foot ulcers. ( Ahmed, A; Boateng, J; Getti, G, 2018) |
| "The objective of this study was to determine if specific species of microorganisms are associated with severe infection and amputation in patients with a diabetic foot infection and to evaluate the effectiveness of clindamycin and ciprofloxacin in this population." | 7.80 | Are clindamycin and ciprofloxacin appropriate for the empirical treatment of diabetic foot infections? ( de Vries, MG; Ekkelenkamp, MB; Peters, EJ, 2014) |
| " Cyclodextrins, via inclusion complexes, increase drug bioavailability and allow an extended release." | 5.56 | Designed sponges based on chitosan and cyclodextrin polymer for a local release of ciprofloxacin in diabetic foot infections. ( Blanchemain, N; Cazaux, F; Chai, F; Foligné, B; Gauzit Amiel, A; Lopez, M; Martel, B; Maton, M; Neut, C; Palomino-Durand, C, 2020) |
| "Seventy-seven patients [25 with clinical suspicion of diabetic foot osteomyelitis (DFOM), 25 with orthopedic device-related infection (ODRI) and 27 with tubercular bone infection] underwent three-phase Tc-methylenediphosphonate bone scintigraphy followed by static Tc-ciprofloxacin imaging at 1, 4 and 24 h." | 5.13 | Efficacy of indigenously developed single vial kit preparation of 99mTc-ciprofloxacin in the detection of bacterial infection: an Indian experience. ( Aggarwal, S; Bhatnagar, A; Bhattacharya, A; Gill, SS; Goni, VG; Kashyap, R; Mittal, BR; Prasad, V; Rai, R; Sharma, S; Singh, AK; Singh, B; Sunil, HV; Taneja, A, 2008) |
| "We evaluated the bacteriological and clinical efficacy of the combination of ciprofloxacin/clindamycin in severe diabetic foot infections and we tried to elucidate the relationship between the vascular status of the lower limbs and the outcome of these infections." | 5.08 | Management and outcome of severe diabetic foot infections. ( Diamantopoulos, EJ; Grigoriadou, M; Haritos, D; Margariti, G; Paniara, O; Raptis, SA; Yfandi, G, 1998) |
| " The duration of treatment for uncomplicated pyelonephritis can be safely shortened to 7 days when using ciprofloxacin." | 4.89 | [Infectious diseases]. ( Malinverni, R; Pittet, R, 2013) |
| "Calcium alginate (CA) wafer dressings were prepared by lyophilization of hydrogels to deliver ciprofloxacin (CIP) directly to the wound site of infected diabetic foot ulcers (DFUs)." | 3.88 | Ciprofloxacin-loaded calcium alginate wafers prepared by freeze-drying technique for potential healing of chronic diabetic foot ulcers. ( Ahmed, A; Boateng, J; Getti, G, 2018) |
| "The objective of this study was to determine if specific species of microorganisms are associated with severe infection and amputation in patients with a diabetic foot infection and to evaluate the effectiveness of clindamycin and ciprofloxacin in this population." | 3.80 | Are clindamycin and ciprofloxacin appropriate for the empirical treatment of diabetic foot infections? ( de Vries, MG; Ekkelenkamp, MB; Peters, EJ, 2014) |
| " Cyclodextrins, via inclusion complexes, increase drug bioavailability and allow an extended release." | 1.56 | Designed sponges based on chitosan and cyclodextrin polymer for a local release of ciprofloxacin in diabetic foot infections. ( Blanchemain, N; Cazaux, F; Chai, F; Foligné, B; Gauzit Amiel, A; Lopez, M; Martel, B; Maton, M; Neut, C; Palomino-Durand, C, 2020) |
| "Diabetic foot ulcers are susceptible to infection and nonmedicated dressings are ineffective because they have no antimicrobial activity." | 1.48 | Calcium alginate-based antimicrobial film dressings for potential healing of infected foot ulcers. ( Ahmed, A; Boateng, J, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (14.81) | 18.2507 |
| 2000's | 6 (22.22) | 29.6817 |
| 2010's | 12 (44.44) | 24.3611 |
| 2020's | 5 (18.52) | 2.80 |
| Authors | Studies |
|---|---|
| Koźmiński, P | 1 |
| Gawęda, W | 1 |
| Rzewuska, M | 1 |
| Kopatys, A | 1 |
| Kujda, S | 1 |
| Dudek, MK | 1 |
| Halik, PK | 1 |
| Królicki, L | 1 |
| Gniazdowska, E | 1 |
| Taki, E | 1 |
| Jabalameli, F | 1 |
| Mohajeri Tehrani, MR | 1 |
| Feizabadi, MM | 1 |
| Beigverdi, R | 1 |
| Emaneini, M | 1 |
| Belik, BM | 1 |
| Chumburidze, IP | 1 |
| Shtilman, MY | 1 |
| Yavruyan, OA | 1 |
| Savchenko, YP | 1 |
| Gauzit Amiel, A | 1 |
| Palomino-Durand, C | 1 |
| Maton, M | 1 |
| Lopez, M | 1 |
| Cazaux, F | 1 |
| Chai, F | 1 |
| Neut, C | 1 |
| Foligné, B | 1 |
| Martel, B | 1 |
| Blanchemain, N | 1 |
| Srivastava, P | 1 |
| Sivashanmugam, K | 1 |
| Townsend, EM | 1 |
| Sherry, L | 1 |
| Kean, R | 1 |
| Hansom, D | 1 |
| Mackay, WG | 1 |
| Williams, C | 1 |
| Butcher, J | 1 |
| Ramage, G | 1 |
| Ahmed, A | 2 |
| Getti, G | 1 |
| Boateng, J | 2 |
| Chakraborty, PP | 1 |
| Roy, A | 1 |
| Bhattacharjee, R | 1 |
| Mukhopadhyay, S | 1 |
| Chowdhury, S | 1 |
| Carro, GV | 1 |
| Carlucci, E | 1 |
| Priore, G | 1 |
| Gette, F | 1 |
| Llanos, MLA | 1 |
| Dicatarina Losada, MV | 1 |
| Noli, ML | 1 |
| Amato, PS | 1 |
| Islam, S | 1 |
| Cawich, SO | 1 |
| Budhooram, S | 1 |
| Harnarayan, P | 1 |
| Mahabir, V | 1 |
| Ramsewak, S | 1 |
| Naraynsingh, V | 1 |
| Carrington, S | 1 |
| Cohall, DH | 1 |
| Gossell-Williams, M | 1 |
| Lindo, JF | 1 |
| de Vries, MG | 1 |
| Ekkelenkamp, MB | 1 |
| Peters, EJ | 1 |
| Akcaer, M | 1 |
| Karakas, A | 1 |
| Tok, D | 1 |
| Coskun, O | 1 |
| Sari, S | 1 |
| Mutluoglu, M | 1 |
| Lipsky, BA | 1 |
| Singh, B | 2 |
| Sunil, HV | 1 |
| Sharma, S | 1 |
| Prasad, V | 1 |
| Kashyap, R | 1 |
| Bhattacharya, A | 1 |
| Mittal, BR | 2 |
| Taneja, A | 1 |
| Rai, R | 1 |
| Goni, VG | 1 |
| Aggarwal, S | 1 |
| Gill, SS | 1 |
| Bhatnagar, A | 1 |
| Singh, AK | 1 |
| van den Berg, FP | 1 |
| Wagenvoort, JH | 1 |
| van der Kleij, AM | 1 |
| Teijink, JA | 1 |
| Pittet, R | 1 |
| Malinverni, R | 1 |
| Kästenbauer, T | 1 |
| Hörnlein, B | 1 |
| Sokol, G | 1 |
| Irsigler, K | 1 |
| Wakefield, MC | 1 |
| Kan, VL | 1 |
| Arora, S | 1 |
| Weiswasser, J | 1 |
| Sidawy, AN | 1 |
| Lobmann, R | 1 |
| Ambrosch, A | 1 |
| Seewald, M | 1 |
| Dietlein, M | 1 |
| Zink, K | 1 |
| Kullmann, KH | 1 |
| Lehnert, H | 1 |
| Dutta, P | 1 |
| Bhansali, A | 1 |
| Masoodi, SR | 1 |
| Ohl, CA | 1 |
| Sullivan, N | 1 |
| Paparello, S | 1 |
| Markowitz, JS | 1 |
| Gill, HS | 1 |
| Devane, CL | 1 |
| Mintzer, JE | 1 |
| Diamantopoulos, EJ | 1 |
| Haritos, D | 1 |
| Yfandi, G | 1 |
| Grigoriadou, M | 1 |
| Margariti, G | 1 |
| Paniara, O | 1 |
| Raptis, SA | 1 |
| Müller, M | 1 |
| Brunner, M | 1 |
| Hollenstein, U | 1 |
| Joukhadar, C | 1 |
| Schmid, R | 1 |
| Minar, E | 1 |
| Ehringer, H | 1 |
| Eichler, HG | 1 |
| Pellizzer, G | 1 |
| Strazzabosco, M | 1 |
| Presi, S | 1 |
| Furlan, F | 1 |
| Lora, L | 1 |
| Benedetti, P | 1 |
| Bonato, M | 1 |
| Erle, G | 1 |
| de Lalla, F | 1 |
2 reviews available for ciprofloxacin and Diabetic Feet
| Article | Year |
|---|---|
[Infectious diseases].
Topics: Anti-Bacterial Agents; Ciprofloxacin; Diabetic Foot; Endocarditis; Humans; Infections; Plant Extract | 2013 |
Nonoperative management of diabetic foot infections.
Topics: Anti-Infective Agents; Bacterial Infections; Cellulitis; Ciprofloxacin; Diabetic Foot; Humans; Osteo | 2003 |
6 trials available for ciprofloxacin and Diabetic Feet
| Article | Year |
|---|---|
Efficacy of indigenously developed single vial kit preparation of 99mTc-ciprofloxacin in the detection of bacterial infection: an Indian experience.
Topics: Adolescent; Adult; Bacterial Infections; Bone Diseases, Infectious; Ciprofloxacin; Diabetic Foot; Di | 2008 |
Evaluation of granulocyte-colony stimulating factor (Filgrastim) in infected diabetic foot ulcers.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Bed Rest; Cellulitis; Ciprofloxacin; Clindamycin | 2003 |
Antibiotic therapy for diabetic foot infections: comparison of cephalosporines with chinolones.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Ceftriaxone; Ciprofloxa | 2004 |
Management and outcome of severe diabetic foot infections.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Blood Glucose; Ciprofloxacin; Clindamycin; Diabe | 1998 |
Penetration of ciprofloxacin into the interstitial space of inflamed foot lesions in non-insulin-dependent diabetes mellitus patients.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Diabetes Mellitus, Type 2; Diabeti | 1999 |
Deep tissue biopsy vs. superficial swab culture monitoring in the microbiological assessment of limb-threatening diabetic foot infection.
Topics: Adult; Bacterial Infections; Biopsy; Ciprofloxacin; Clindamycin; Corynebacterium; Diabetic Foot; Dru | 2001 |
19 other studies available for ciprofloxacin and Diabetic Feet
| Article | Year |
|---|---|
Physicochemical and Biological Study of
Topics: Ciprofloxacin; Diabetes Mellitus; Diabetic Foot; Gallium Radioisotopes; Humans; Radiopharmaceuticals | 2021 |
Microbial Profile and Antibiotic Susceptibility Pattern in Diabetic Patients with Mild, Moderate, and Severe Foot Infections in Tehran.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Diabetes Mellitus; Diabetic Fo | 2022 |
[Complex treatment of patients with pyo-necrotic complications of the neuropathic form of diabetic foot syndrome].
Topics: Adjuvants, Immunologic; Amputation, Surgical; Anti-Bacterial Agents; Ciprofloxacin; Combined Modalit | 2020 |
Designed sponges based on chitosan and cyclodextrin polymer for a local release of ciprofloxacin in diabetic foot infections.
Topics: Anti-Bacterial Agents; Cellulose; Chitosan; Ciprofloxacin; Cyclodextrins; Diabetes Mellitus; Diabeti | 2020 |
Efficacy of sub-MIC level of meropenem and ciprofloxacin against extensive drug-resistant (XDR) Pseudomonas aeruginosa isolates of diabetic foot ulcer patients.
Topics: Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Diabetic Foot; Drug Resistance; Humans; Merope | 2021 |
Implications of Antimicrobial Combinations in Complex Wound Biofilms Containing Fungi.
Topics: Anti-Bacterial Agents; Antifungal Agents; Biofilms; Candida albicans; Ciprofloxacin; Diabetic Foot; | 2017 |
Ciprofloxacin-loaded calcium alginate wafers prepared by freeze-drying technique for potential healing of chronic diabetic foot ulcers.
Topics: Alginates; Anti-Bacterial Agents; Bandages; Cell Line; Cell Proliferation; Ciprofloxacin; Diabetic F | 2018 |
Reversible Secondary Osteolysis in Diabetic Foot Infection.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Diabetic Foot; Humans; Male; Middle Aged; Osteolysis; Soft Tis | 2017 |
Calcium alginate-based antimicrobial film dressings for potential healing of infected foot ulcers.
Topics: Alginates; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Bandages; Biocompatib | 2018 |
[Infections in diabetic foot. Choice of empirical antibiotic regimen].
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Diabetes Mellit | 2019 |
Microbial profile of diabetic foot infections in Trinidad and Tobago.
Topics: Adult; Aged; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Diabetic Foot; Drug Resistance, Mult | 2013 |
The antimicrobial screening of a Barbadian medicinal plant with indications for use in the treatment of diabetic wound infections.
Topics: Anti-Bacterial Agents; Bacterial Infections; Barbados; Ciprofloxacin; Colony-Forming Units Assay; Di | 2012 |
Are clindamycin and ciprofloxacin appropriate for the empirical treatment of diabetic foot infections?
Topics: Aged; Amputation, Surgical; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Clindamycin; | 2014 |
Eosinophilic pneumonia: Daptomycin-induced lung complication.
Topics: Abscess; Amputation Stumps; Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Combined Modality The | 2016 |
Non-surgical treatment of diabetic foot osteomyelitis.
Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Diabetes Mellitus, Type 2; Diabetic Foot; Humans; Male; | 2017 |
Ciprofloxacin-induced hemorrhagic vasculitis.
Topics: Aged; Aged, 80 and over; Amputation, Surgical; Anti-Infective Agents; Ciprofloxacin; Diabetic Foot; | 2010 |
Instant 99mTc-ciprofloxacin scintigraphy for the diagnosis of osteomyelitis in the diabetic foot.
Topics: Adult; Aged; Ciprofloxacin; Diabetic Foot; Escherichia coli; Humans; Middle Aged; Organotechnetium C | 2006 |
Streptococcus sanguis bacteremia during ciprofloxacin therapy of a diabetic foot ulcer.
Topics: Bacteremia; Ciprofloxacin; Clindamycin; Diabetes Mellitus, Type 1; Diabetic Foot; Drug Resistance, M | 1994 |
Fluoroquinolone inhibition of clozapine metabolism.
Topics: Aged; Anti-Infective Agents; Ciprofloxacin; Clozapine; Comorbidity; Dementia, Multi-Infarct; Diabeti | 1997 |